<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ginseng Res</journal-id><journal-id journal-id-type="iso-abbrev">J Ginseng Res</journal-id><journal-id journal-id-type="publisher-id">JGR</journal-id><journal-title-group><journal-title>Journal of Ginseng Research</journal-title></journal-title-group><issn pub-type="ppub">1226-8453</issn><issn pub-type="epub">2093-4947</issn><publisher><publisher-name>The Korean Society of Ginseng</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23717127</article-id><article-id pub-id-type="pmc">3659593</article-id><article-id pub-id-type="publisher-id">grosbr-36-263</article-id><article-id pub-id-type="doi">10.5142/jgr.2012.36.3.263</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Korean Red Ginseng Saponin Fraction Downregulates Proinflammatory Mediators in LPS Stimulated RAW264.7 Cells and Protects Mice against Endotoxic Shock</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yayeh</surname><given-names>Taddessee</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor1">#</xref></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Kun-Ho</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="cor1">#</xref></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Hye Yoon</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Ji-Hoon</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Yong-Bum</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kwak</surname><given-names>Yi-Seong</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Heun-Soo</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Jae Youl</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Oh</surname><given-names>Jae-Wook</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Sang-Keun</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="cor2">*</xref></contrib><contrib contrib-type="author"><name><surname>Rhee</surname><given-names>Man Hee</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor2">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>College of Veterinary Medicine and Stem Cell Research Therapeutic Institute, Kyungpook National University, Daegu 702-701, Korea</aff><aff id="A2"><label>2</label>College of Veterinary Medicine, Chungnam National University, Daejeon 305-764, Korea</aff><aff id="A3"><label>3</label>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Korea</aff><aff id="A4"><label>4</label>Ginseng Corporation Central Research Institute, Daejeon 305-805, Korea</aff><aff id="A5"><label>5</label>Metabolab Inc., Seoul 110-799, Korea</aff><aff id="A6"><label>6</label>College of Animal Bioscience &#x00026; Technology, Konkuk University, Seoul 143-701, Korea</aff><author-notes><corresp id="cor1"><label>#</label> These authors equally contributed to this work.</corresp><corresp id="cor2"><label>*</label>Corresponding authors E-mail: <email>rheemh@knu.ac.kr</email> Tel: +82-53-950-5967, Fax: +82-53-950-5955 E-mail: <email>kskkim@cnu.ac.kr</email> Tel: +82-42-821-6754, Fax: +82-42-821-8903</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2012</year></pub-date><volume>36</volume><issue>3</issue><fpage>263</fpage><lpage>269</lpage><history><date date-type="received"><day>02</day><month>3</month><year>2012</year></date><date date-type="rev-recd"><day>23</day><month>3</month><year>2012</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012, The Korean Society of Ginseng</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Korean red ginseng has shown therapeutic effects for a number of disease conditions. However, little is known about the antiinflammatory effect of Korean red ginseng saponin fraction (RGSF) <italic>in vitro</italic> and <italic>in vivo</italic>. Therefore, in this study, we showed that RGSF containing 20(S)-protopanaxadiol type saponins inhibited nitric oxide production and attenuated the release of tumor necrotic factor (TNF)-&#x003b1;, interleukin (IL)-6, granulocyte monocyte colony stimulating factor (GMCSF), and macrophage chemo-attractant protein-1 in lipopolysaccharide (LPS) stimulated murine macrophage RAW264.7 cells. Moreover, RGSF down-regulated the mRNA expressions of inducible nitric oxide synthase, cyclooxyginase-2, IL-1&#x003b2;, TNF-&#x003b1;, GMCSF, and IL-6. Furthermore, RGSF reduced the level of TNF-&#x003b1; in the serum and protected mice against LPS mediated endotoxic shock. In conclusion, these results indicated that ginsenosides from RGSF and their metabolites could be potential sources of therapeutic agents against inflammation.</p></abstract><kwd-group kwd-group-type="author"><kwd><italic>Panax ginseng</italic></kwd><kwd>20(S)-protopanaxadiol saponins</kwd><kwd>Pro-inflammatory cytokines</kwd><kwd>Endotoxic shock</kwd><kwd>Macrophages</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Macrophages play a central role in inflammatory processes through the release of pro-inflammatory mediators and cytokines such as tumor necrosis factor (TNF)-&#x003b1;, interleukin (IL)-1&#x003b2;, IL-6, macrophage chemo-attractant protein (MCP)-1 and granulocyte macrophage colony stimulating factor (GMCSF), nitric oxide (NO) and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) <xref ref-type="bibr" rid="B001">[1</xref>-<xref ref-type="bibr" rid="B003">3]</xref>. Lipopolysaccharide (LPS) triggers inflammation through the release of the afore-mentioned inflammatory mediators <xref ref-type="bibr" rid="B004">[4</xref>-<xref ref-type="bibr" rid="B007">7]</xref>, which could be employed for the design, development and study of new anti-inflammatory agents.</p><p>Recently, a great deal of interest has been growing on the use of natural products to develop potential candidate drugs for the treatment of chronic diseases like rheumatoid arthritis (RA) <xref ref-type="bibr" rid="B008">[8</xref>,<xref ref-type="bibr" rid="B009">9]</xref>. Phytotherapeutic agents with the capacity to modulate the inflammatory response and reduce the subsequent tissue injury are required, while minimizing side effects of long-term applications. In this regard, anti-inflammatory agents of plant origin such as <italic>Panax ginseng</italic> could be considered as alternative candidates.</p><p>Previous works have indicated that the root of <italic>P. ginseng</italic> is the major oriental folk medicine that has been used for the treatment of a variety of ailments in Asia <xref ref-type="bibr" rid="B010">[10</xref>,<xref ref-type="bibr" rid="B011">11]</xref>. Ginseng contains many active components such as ginsenosides, polysaccharides, peptides, fatty acids, and mineral oils <xref ref-type="bibr" rid="B012">[12]</xref>, of which ginsenosides (steroidal saponins) are believed to be the main components responsible for most of the pharmacological and immunological actions <xref ref-type="bibr" rid="B013">[13</xref>,<xref ref-type="bibr" rid="B014">14]</xref>. Jia et al. <xref ref-type="bibr" rid="B010">[10]</xref> extensively reviewed the anti-hyperglycemic, aphrodisiac, cancer cell apoptotic, anti-oxidant and anti-inflammatory effects of ginseng. Saponin components of ginsenosides are divided into two different classes, 20(S)-protopanaxdiol (PPD) type saponins (e.g., Rb1, Rb2, Rc, and Rd) and 20(S)-protopanaxtriol (PPT) type saponins (e.g., Re, Rf, Rg1, and Rg2) <xref ref-type="bibr" rid="B015">[15]</xref>. Previous investigations reported that ginsenosides of 20(S) PPT type saponins have shown anti-cancer <xref ref-type="bibr" rid="B016">[16]</xref> and anti-inflammatory <xref ref-type="bibr" rid="B017">[17]</xref> effects. However, little is known about the <italic>in vitro</italic> and <italic>in vivo</italic> anti-inflammatory effects of PPD-rich fraction of ginseng. In this study, therefore, we showed that PPD-rich red ginseng saponin fraction (RGSF) inhibits the release of pro-inflammatory mediators <italic>in vitro</italic> and protects mice against endotoxin mediated shock.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Materials</title><p>Korean red ginseng was kindly provided by the Research Institute of Technology, Korea Ginseng Corporation (Daejeon, Korea). RAW264.7 cells were obtained from the Korean Cell Line Bank (Seoul, Korea). Reverse transcription (RT) and polymerase chain reaction (PCR) premixes were from Bioneer Co. (Daejon, Korea). LPS was from Sigma (St Louis, MO, USA). All other reagents were obtained from Sigma unless indicated.</p></sec><sec><title>Red ginseng saponin fraction extraction and preparation</title><p>In brief, the Korean red ginseng was extracted with ethanol and the extract was air-dried at 60&#x02103; for 2 d. The powder was then subjected to three time&#x02019;s aqueous extraction at 95&#x02103; to 100&#x02103;. The resultant water extracts were ultrafilterd with a pore size of 100,000 &#x003bc;m. Finally, the filtrate was harvested and stored as RGSF for further identification of major chemical components (PPD saponins) by HPLC profile analysis (<xref ref-type="fig" rid="F001">Fig. 1</xref>).</p><fig id="F001" orientation="portrait" position="float"><label>Fig. 1.</label><caption><title>HPLC analysis of ginsenoside contents from red ginseng saponin fraction.</title></caption><graphic xlink:href="grosbr-36-263-g001"/></fig></sec><sec><title>Cell culture</title><p>RAW264.7 cells were maintained in Dulbecco&#x02019;s modified Eagle medium supplemented with 100 U/mL of penicillin, 100 &#x003bc;g/mL of streptomycin and 5% fetal bovine serum. Cells were grown at 37&#x02103; and 5% CO<sub>2</sub> in humidified air.</p></sec><sec><title>Nitric oxide assay and cell viability test</title><p>NO and cell viability assays were performed as described during our previous work <xref ref-type="bibr" rid="B018">[18]</xref>. Briefly, RAW264.7 cells (1&#x000d7;10<sup>6</sup> cells/mL) were pre-incubated with RGSF (25, 50, 100, and 200 &#x003bc;g/mL) or vehicle for 30 min and then stimulated with LPS (100 ng/mL) for 18 h. One-hundred microliter of cell supernatant from each well were transferred into 96-well microplates and mixed with an equal volume of Griess reagent at room temperature. The absorbance at 540 nm was determined by a Spectramax 250 microplate reader. For cell viability test, 30 &#x003bc;L of 5 mg/mL 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reagent was added to the culture plates and cell viability test was performed based on the reduction of MTT reagent into an insoluble, dark purple formazan product in viable cells.</p></sec><sec><title>Total RNA isolation and semi-quantitative reverse transcriptase polymerase chain reaction</title><p>Total RNA was isolated from LPS treated and untreated- RAW264.7 cells using Easy Blue Reagent (iNtRON Biotechnology Co., Daejeon, Korea), according to the manufacturer&#x02019;s protocol. The extracted total RNA was then used for semi-quantitative RT-PCR using RT premix (Bioneer Co., Daejeon, Korea). Briefly, 2 &#x003bc;g of total RNA was incubated with oligo-dT<sub>18</sub> at 70&#x02103; for 5 min and cooled on ice for 3 min, and then the reaction mixture containing RT premix was incubated for 90 min at 42.5&#x02103; with a final inactivation of reverse transcriptase at 95&#x02103; for 5 min. The PCR reaction was continued using a PCR premix (Bioneer Co.) with appropriate sense and antisense primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH; sense primer, 5&#x02019;-CAC TCA CGG CAA ATT CAA CGG C-3&#x02019;; antisense primer, 5&#x02019;-CCT TGG CAG CAC CAG TGG ATG CAG G-3&#x02019;), inducible nitric oxide synthase (iNOS; sense primer, 5&#x02019;- CCC TTC CGA AGT TTC TGG CAG CAG C-3&#x02019;; antisense primer, 5&#x02019;- GGC TGT CAG AGC CTC GTG GCT TTG G-3&#x02019;), cyclooxyginase-2 (COX-2; sense primer, TCTCAGCACCCACCCGCTCA; anti-sense, GCCCCGTAGACCCTGCTCGA), IL-1&#x003b2; (sense primer, 5&#x02019;- CAG GAT GAG GAC ATG AGC ACC-3&#x02019;; antisense primer, 5&#x02019;- CTC TGC AGA CTC AAA CTC CAC-3&#x02019;), IL-6 (sense primer, GCTGGAGTCACAGAAGGAGTGGC; anti-sense primer, GGCATAACGCACTAGGTTTGCCG), GMCSF (sense primer, ACTCTGCTCACGAAGGAACTCAGC; anti-sense primer, CACAGCTCGGAAGAGCATCGCA), and TNF-&#x003b1; (sense primer, 5&#x02019;- TTG ACC TCA GCG CTG AGT TG -3&#x02019;; antisense primer, 5&#x02019;- CCT GTA GCC CAC GTC GTA GC-3&#x02019;), under incubation conditions of 95&#x02103; predenaturation for 5 min and 35 cycles of &#x02018;95&#x02103; denaturation for 45 sec, 55 and 60&#x02103; annealing for 45 s, 72&#x02103; extension for 45 s,&#x02019; and a final elongation period of 10 min at 72&#x02103;. Next, PCR products were separated using 1% agarose gel electrophoresis (BioRad Co.) and relative band intensity levels were determined by Eagle Eyes Image Analysis software (Stratagene Co., La Jolla, CA, USA,). The resulting density levels were calculated relative to the corresponding density level of GAPDH (housekeeping gene) from the same RNA samples to make a bar graph of gene expressions.</p></sec><sec><title>Enzyme-linked immunosorbent assay</title><p>RAW264.7 cells were preincubated with RGSF for 30 min before LPS stimulation for 24 h, and cytokine contents in the culture medium were measured by enzyme-linked immunosorbent assay (ELISA) using anti-mouse TNF-&#x003b1;, IL-6, GMCSF and MCP-1 antibodies and bio-tinylated secondary antibodies following the manufacturer&#x02019;s instruction (Millipore Milliplex Mouse Cytokine/ Chemokine kit; Millipore, St. Charles, MO, USA).</p></sec><sec><title>Endotoxin induced shock in mice</title><p>LPS was used to induce endotoxic shock in ICR mice (male, 6-8 weeks old) in accordance with Guidelines for the Care and Use of Laboratory Animals. Three groups of mice (<italic>n</italic>=10) were pretreated for 1 h orally with or without RGSF (50 and 200 mg/kg dissolved in water) followed by a single dose of intraperitoneal LPS (10 mg/kg) was administered at day one and then mice were routinely examined for 1 wk to determine the survival rate. For TNF-&#x003b1; assay, blood was collected from each group of mice using retro-orbital bleeding after 6 h of LPS treatment, and the level of TNF-&#x003b1; in the serum was determined by ELISA using specific antibodies (Biosource International Inc.) according to the manufacturer&#x02019;s instructions.</p></sec><sec><title>Statistical analysis</title><p>Data were represented as the means&#x000b1;SEM of three independent experiments, conducted in triplicate. A <italic>p</italic>-value less than 0.05 were considered statistically significant.</p></sec></sec><sec><title>RESULTS AND DISCUSSION</title><sec><title>Red ginseng saponin fraction inhibits nitric oxide production in LPS-stimulated RAW264.7 murine macrophage cells</title><p>To assess whether RGSF attenuates overproduction of NO which is a potent mediator of cellular damage in a wide range of pathological conditions <xref ref-type="bibr" rid="B019">[19]</xref>, RAW264.7 cells were pre-treated with different concentrations of RGSF (25, 50, 100, and 200 &#x003bc;g/mL) and then stimulated with LPS (0.1 &#x003bc;g/mL) to induce inflammation. RGSF at the indicated concentrations exhibited inhibitory effect on the production of NO in murine RAW264.7 macrophage cell line (<xref ref-type="fig" rid="F002">Fig. 2</xref>B).</p><fig id="F002" orientation="portrait" position="float"><label>Fig. 2.</label><caption><title>Effect of red ginseng saponin fraction (RGSF) on cell viability and nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. RAW cells were pre-treated with RGSF (25, 50,100, 200 &#x003bc;g/mL) or vehicle and stimulated by LPS for 24 h. 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay was carried out to check the cytotoxic effect of RGSF (A), and then its inhibitory effect on the release of NO was determined (B). Each bar graph represents mean&#x000b1;SE of at least 4 independent experiments. *<italic>p</italic>&#x0003c;0.05, 42;*<italic>p</italic>&#x0003c;0.01, ***<italic>p</italic>&#x0003c;0.005 vs. LPS.</title></caption><graphic xlink:href="grosbr-36-263-g002"/></fig><p>Since overproduction of NO is produced by iNOS, we further checked if this saponin fraction of ginseng had its effect at the transcriptional level of this inducible enzyme. As shown in <xref ref-type="fig" rid="F003">Fig. 3</xref>A and <xref ref-type="fig" rid="F003">3</xref>B, RGSF not only showed its downregulating effect on NO in LPS stimulated RAW264.7 cells but also revealed its inhibitory role on iNOS gene at the transcriptional level.</p><fig id="F003" orientation="portrait" position="float"><label>Fig. 3.</label><caption><title>Effect of red ginseng saponin fraction (RGSF) on proinflammatory mediators mRNA expressions in lipopolysaccharide (LPS) stimulated RAW264.7 cells. Cells were pretreated for 30 min with the indicated concentrations of RGSF, followed by stimulation with LPS for 24 h. RGSF dose-dependently inhibited mRNA expression of inducible nitric oxide synthase (iNOS) (A,B), cyclooxyginase (COX)-2 (A,C), interleukin (IL)-1&#x003b2; (A,D), tumor necrosis factor (TNF)-&#x003b1; (A,E), IL-6 (A,F), and granulocyte macrophage colony stimulating factor (GMCSF) (G) levels as assessed by reverse transcriptase polymerase chain reaction. The mRNA band density ratios were determined relative to the loading control (&#x003b2;-actin). Each bar graph represents mean&#x000b1;SE of at least four independent experiments. **<italic>p</italic>&#x0003c;0.01, ***<italic>p</italic>&#x0003c;0.005 vs. LPS.</title></caption><graphic xlink:href="grosbr-36-263-g003"/></fig><p>Previously, it was reported that cross talks between iNOS and COX-2 exist at different pathological conditions <xref ref-type="bibr" rid="B020">[20]</xref>, suggesting that this PPD rich fraction of Korean RGSF could also possess inhibitory effect at the transcriptional level of COX-2 (<xref ref-type="fig" rid="F003">Fig. 3</xref>A, C), which is a key enzyme involved in the synthesis of another inflammatory mediator (PGE<sub>2</sub>) that exists in cancer related inflammation <xref ref-type="bibr" rid="B021">[21</xref>-<xref ref-type="bibr" rid="B023">23]</xref>.</p><p>Interestingly, all these observed inhibitory effects were attributed to the effect of PPD rich RGSF since the cytotoxic effect of this extract was excluded at the beginning of our work using MTT assay (<xref ref-type="fig" rid="F002">Fig. 2</xref>A).</p></sec><sec><title>Red ginseng saponin fraction attenuates the release of TNF-&#x003b1;, IL-6, GMCSF, and MCP-1 in LPS-induced RAW264.7 cells</title><p>Since black Korean ginseng rich in Rh2 and Rg3 revealed its inhibitory effect on the release of TNF-&#x003b1; in LPS treated peritoneal macrophages obtained from mice <xref ref-type="bibr" rid="B024">[24]</xref>. Moreover, topical application of RGSF endowed with Rh2 and Rg3 has shown anti-inflammatory effect in vivo through the abrogation of TNF-&#x003b1; and IL-4 in an animal model of acute dermatitis <xref ref-type="bibr" rid="B025">[25]</xref>. In line with these reports, we found that RGSF (50, 100, and 200 &#x003bc;g/mL) rich in Rb1, Rb2, Rg3, and Rc (<xref ref-type="fig" rid="F001">Fig. 1</xref>) showed dose dependent attenuation of TNF-&#x003b1; mRNA expression (<xref ref-type="fig" rid="F003">Fig. 3</xref>A, E) and secretion (<xref ref-type="fig" rid="F004">Fig. 4</xref>A) in LPS stimulated RAW264.7 cells. Likewise, RGSF obviously inhibited mRNA expression of IL-1&#x003b2; (<xref ref-type="fig" rid="F003">Fig. 3</xref>A, D), IL-6 (<xref ref-type="fig" rid="F003">Fig. 3</xref>A, F), and GMCSF (<xref ref-type="fig" rid="F003">Fig. 3</xref>A, G) with a concentration above 50 &#x003bc;g/ mL.</p><fig id="F004" orientation="portrait" position="float"><label>Fig. 4.</label><caption><title>Effect of red ginseng saponin fraction (RGSF) on the production of pro-inflammatory cytokines in lipopolysaccharide (LPS) stimulated RAW264.7 cells. After pretreatment of cells with various concentration of RGSF, the amount of tumor necrosis factor (TNF)-&#x003b1; (A), interleukin (IL)- 6 (B), granulocyte macrophage colony stimulating factor (GMCSF) (C), and chemo-attractant protein (MCP)-1 (D) were determined using enzyme immunoassay. Each bar graph represents mean&#x000b1;SE of at least four independent experiments. *<italic>p</italic>&#x0003c;0.05, **<italic>p</italic>&#x0003c;0.01 vs. LPS.</title></caption><graphic xlink:href="grosbr-36-263-g004"/></fig><p>Furthermore, RGSF moderately inhibited the release of GMCSF (<xref ref-type="fig" rid="F004">Fig. 4</xref>C) and strongly abrogated MCP-1 (<xref ref-type="fig" rid="F004">Fig. 4</xref>D) secretion in LPS treated RAW264.7 cells, suggesting that ginsenosides of PPD type acquired from Korean red ginseng might have pleiotropic effects on the secretion of proinflammatory cytokines from macrophages exposed to LPS. These results could be further supported by the fact that different ginsenosides acquired from Korean red ginseng posses various pharmacological effects <xref ref-type="bibr" rid="B026">[26]</xref>.</p></sec><sec><title>Red ginseng saponin fraction attenuates the level of TNF-&#x003b1; in the serum and improves the survival rate of mice in LPS induced shock</title><p>To determined if the <italic>in vitro</italic> anti-inflammatory effects of RGSF on LPS stimulated RAW264.7 cells coincides with the <italic>in vivo</italic> experimental study, we determined the level of TNF-&#x003b1; and the survival rate of mice administered with RGSF and/or LPS (<xref ref-type="fig" rid="F005">Fig. 5</xref>A). RGSF diminished the level of TNF-&#x003b1; <italic>in vivo</italic> as well, and improved the survival rate of mice by 20% at a dose of 50 mg/kg, and further rescued mice from endotoxin triggered death when 200 mg/kg RGSF was used (<xref ref-type="fig" rid="F005">Fig. 5</xref>B).</p><fig id="F005" orientation="portrait" position="float"><label>Fig. 5.</label><caption><title>Effect of red ginseng saponin fraction (RGSF) in lipopolysaccharide (LPS) induced endotoxic shock in mice. Mice were pretreated with or without RGSF (50-200 mg/kg) orally for 1 h and then administered with LPS (10 mg/kg) for 7 d. After 6 h of LPS stimulation, sera were collected for tumor necrosis factor (TNF)-&#x003b1; assay (A), and then mice were followed for their survival for a week (B). *<italic>p</italic>&#x0003c;0.05 vs. LPS considered as significant.</title></caption><graphic xlink:href="grosbr-36-263-g005"/></fig><p>A previous study revealed that ginsenosides showed anti-inflammatory effects <italic>in vitro</italic>
<xref ref-type="bibr" rid="B017">[17</xref>,<xref ref-type="bibr" rid="B027">27]</xref> and, yet there was scarcity of data pertaining to their effects <italic>in vivo</italic>. This study, therefore, showed that the <italic>in vitro</italic> anti-inflammatory effect of RGSF was consistent with the <italic>in vivo</italic> protective effect against endotoxin mediated shock, suggesting the effect of ginsenosides was not limited to <italic>in vitro</italic>. This could also be further supported by our observation on the anti-arthritic effect of RGSF in collagen type II induced rheumatoid arthritis in mice (unpublished result).</p><p>In conclusion, our work showed that PPD rich RGSF attenuates the release of NO and proinflammatory cytokines in LPS stimulated murine macrophage RAW264.7 cells. Furthermore, RGSF protected mice against endotoxin mediated shock. However, data pertaining to the associated receptors and cellular signaling mechanisms during inflammation remained elusive. Thus, further work may warrant for the detailed cellular signaling mechanisms of individual ginsenosides.</p></sec></sec></body><back><ack><p>This research was supported by a grant from Korean Society of Ginseng Funded by Korean Ginseng Corporation (2011).</p></ack><ref-list><ref id="B001"><label>1</label><element-citation publication-type="journal"><person-group><name><surname>Nathan</surname><given-names>C</given-names></name></person-group><article-title>Nitric oxide as a secretory product of mamma-lian cells.</article-title><source>FASEB J</source><year>1992</year><volume>6</volume><fpage>3051</fpage><lpage>3064</lpage><pub-id pub-id-type="pmid">1381691</pub-id></element-citation></ref><ref id="B002"><label>2</label><element-citation publication-type="journal"><person-group><name><surname>Laskin</surname><given-names>DL</given-names></name><name><surname>Pendino</surname><given-names>KJ</given-names></name></person-group><article-title>Macrophages and inflammatory mediators in tissue injury.</article-title><source>Annu Rev Pharmacol Toxicol</source><year>1995</year><volume>35</volume><fpage>655</fpage><lpage>677</lpage><pub-id pub-id-type="pmid">7598511</pub-id></element-citation></ref><ref id="B003"><label>3</label><element-citation publication-type="journal"><person-group><name><surname>Thanawastien</surname><given-names>A</given-names></name><name><surname>Montor</surname><given-names>WR</given-names></name><name><surname>Labaer</surname><given-names>J</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name><name><surname>Yoon</surname><given-names>SS</given-names></name></person-group><article-title>Vibrio cholerae proteome-wide screen for immunostimulatory proteins identifies phosphatidylserine decarboxylase as a novel Toll-like receptor 4 agonist.</article-title><source>PLoS Pathog</source><year>2009</year><volume>5</volume><fpage>e1000556</fpage><pub-id pub-id-type="pmid">19696891</pub-id></element-citation></ref><ref id="B004"><label>4</label><element-citation publication-type="journal"><person-group><name><surname>Gallucci</surname><given-names>S</given-names></name><name><surname>Provenzano</surname><given-names>C</given-names></name><name><surname>Mazzarelli</surname><given-names>P</given-names></name><name><surname>Scuderi</surname><given-names>F</given-names></name><name><surname>Bartoccioni</surname><given-names>E</given-names></name></person-group><article-title>Myoblasts produce IL-6 in response to inflammatory stimuli.</article-title><source>Int Immunol</source><year>1998</year><volume>10</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">9576614</pub-id></element-citation></ref><ref id="B005"><label>5</label><element-citation publication-type="journal"><person-group><name><surname>Klein</surname><given-names>RD</given-names></name><name><surname>Su</surname><given-names>GL</given-names></name><name><surname>Aminlari</surname><given-names>A</given-names></name><name><surname>Alarcon</surname><given-names>WH</given-names></name><name><surname>Wang</surname><given-names>SC</given-names></name></person-group><article-title>Pulmonary LPS-binding protein (LBP) upregulation following LPS-mediated injury.</article-title><source>J Surg Res</source><year>1998</year><volume>78</volume><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9733616</pub-id></element-citation></ref><ref id="B006"><label>6</label><element-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>YB</given-names></name><name><surname>Nagai</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>SU</given-names></name></person-group><article-title>Cytokines, chemokines, and cytokine receptors in human microglia.</article-title><source>J Neurosci Res</source><year>2002</year><volume>69</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">12111820</pub-id></element-citation></ref><ref id="B007"><label>7</label><element-citation publication-type="journal"><person-group><name><surname>Cho</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>TW</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Song</surname><given-names>JC</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>HM</given-names></name><name><surname>Sung</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Song</surname><given-names>YB</given-names></name><etal>et al</etal></person-group><article-title>Radical scavenging and anti-inflammatory activity of extracts from Opuntia humifusa Raf.</article-title><source>J Pharm Pharmacol</source><year>2006</year><volume>58</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">16393471</pub-id></element-citation></ref><ref id="B008"><label>8</label><element-citation publication-type="journal"><person-group><name><surname>Imboden</surname><given-names>JB</given-names></name></person-group><article-title>The immunopathogenesis of rheumatoid arthritis.</article-title><source>Annu Rev Pathol</source><year>2009</year><volume>4</volume><fpage>417</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">18954286</pub-id></element-citation></ref><ref id="B009"><label>9</label><element-citation publication-type="journal"><person-group><name><surname>Chen</surname><given-names>S</given-names></name></person-group><article-title>Natural products triggering biological targets: a review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis.</article-title><source>Curr Drug Targets</source><year>2011</year><volume>12</volume><fpage>288</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">20955151</pub-id></element-citation></ref><ref id="B010"><label>10</label><element-citation publication-type="journal"><person-group><name><surname>Jia</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>XJ</given-names></name></person-group><article-title>Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.</article-title><source>Curr Med Chem</source><year>2009</year><volume>16</volume><fpage>2924</fpage><lpage>2942</lpage><pub-id pub-id-type="pmid">19689273</pub-id></element-citation></ref><ref id="B011"><label>11</label><element-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name></person-group><article-title>Trends in ginseng research in 2010.</article-title><source>J Ginseng Res</source><year>2011</year><volume>35</volume><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.5142/jgr.2011.35.4.389</pub-id></element-citation></ref><ref id="B012"><label>12</label><element-citation publication-type="journal"><person-group><name><surname>Gillis</surname><given-names>CN</given-names></name></person-group><article-title>Panax ginseng pharmacology: a nitric oxide link?</article-title><source>Biochem Pharmacol</source><year>1997</year><volume>54</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9296344</pub-id></element-citation></ref><ref id="B013"><label>13</label><element-citation publication-type="journal"><person-group><name><surname>Attele</surname><given-names>AS</given-names></name><name><surname>Wu</surname><given-names>JA</given-names></name><name><surname>Yuan</surname><given-names>CS</given-names></name></person-group><article-title>Ginseng pharmacology: multiple constituents and multiple actions.</article-title><source>Biochem Pharmacol</source><year>1999</year><volume>58</volume><fpage>1685</fpage><lpage>1693</lpage><pub-id pub-id-type="pmid">10571242</pub-id></element-citation></ref><ref id="B014"><label>14</label><element-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Shim</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>YB</given-names></name><name><surname>Kwon</surname><given-names>J</given-names></name></person-group><article-title>Modulation of LPS-stimulated astroglial activation by ginseng total saponins.</article-title><source>J Ginseng Res</source><year>2011</year><volume>35</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.5142/jgr.2011.35.1.080</pub-id></element-citation></ref><ref id="B015"><label>15</label><element-citation publication-type="journal"><person-group><name><surname>Yuan</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>CZ</given-names></name><name><surname>Wicks</surname><given-names>SM</given-names></name><name><surname>Qi</surname><given-names>LW</given-names></name></person-group><article-title>Chemical and pharmacological studies of saponins with a focus on American ginseng.</article-title><source>J Ginseng Res</source><year>2010</year><volume>34</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.5142/jgr.2010.34.3.160</pub-id><pub-id pub-id-type="pmid">21359120</pub-id></element-citation></ref><ref id="B016"><label>16</label><element-citation publication-type="journal"><person-group><name><surname>Ng</surname><given-names>F</given-names></name><name><surname>Yun</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Danishefsky</surname><given-names>SJ</given-names></name><name><surname>Fahey</surname><given-names>J</given-names></name><name><surname>Stephenson</surname><given-names>K</given-names></name><name><surname>Flexner</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name></person-group><article-title>(3R, 9R, 10R)-panaxytriol: a molecular-based nutraceutical with possible application to cancer prevention and treatment.</article-title><source>Tetrahedron Lett</source><year>2008</year><volume>49</volume><fpage>7178</fpage><lpage>7179</lpage><pub-id pub-id-type="pmid">20011028</pub-id></element-citation></ref><ref id="B017"><label>17</label><element-citation publication-type="journal"><person-group><name><surname>Oh</surname><given-names>GS</given-names></name><name><surname>Pae</surname><given-names>HO</given-names></name><name><surname>Choi</surname><given-names>BM</given-names></name><name><surname>Seo</surname><given-names>EA</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Shin</surname><given-names>MK</given-names></name><name><surname>Kim</surname><given-names>JD</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Chung</surname><given-names>HT</given-names></name></person-group><article-title>20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappa B in RAW 264.7 macrophages stimulated with lipopolysaccharide.</article-title><source>Cancer Lett</source><year>2004</year><volume>205</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">15036657</pub-id></element-citation></ref><ref id="B018"><label>18</label><element-citation publication-type="journal"><person-group><name><surname>Yayeh</surname><given-names>T</given-names></name><name><surname>Oh</surname><given-names>WJ</given-names></name><name><surname>Park</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Cho</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>IK</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Hong</surname><given-names>SB</given-names></name><name><surname>Yun</surname><given-names>BS</given-names></name><etal>et al</etal></person-group><article-title>Phellinus baumii ethyl acetate extract inhibits lipopolysaccharide-induced iNOS, COX-2, and proinflammatory cytokine expression in RAW264.7 cells.</article-title><source>J Nat Med</source><year>2012</year><volume>66</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">21656334</pub-id></element-citation></ref><ref id="B019"><label>19</label><element-citation publication-type="journal"><person-group><name><surname>Pacher</surname><given-names>P</given-names></name><name><surname>Beckman</surname><given-names>JS</given-names></name><name><surname>Liaudet</surname><given-names>L</given-names></name></person-group><article-title>Nitric oxide and peroxynitrite in health and disease.</article-title><source>Physiol Rev</source><year>2007</year><volume>87</volume><fpage>315</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">17237348</pub-id></element-citation></ref><ref id="B020"><label>20</label><element-citation publication-type="journal"><person-group><name><surname>Franco</surname><given-names>L</given-names></name><name><surname>Talamini</surname><given-names>G</given-names></name></person-group><article-title>Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis.</article-title><source>Med Princ Pract</source><year>2009</year><volume>18</volume><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">19797925</pub-id></element-citation></ref><ref id="B021"><label>21</label><element-citation publication-type="journal"><person-group><name><surname>Milella</surname><given-names>M</given-names></name><name><surname>Metro</surname><given-names>G</given-names></name><name><surname>Gelibter</surname><given-names>A</given-names></name><name><surname>Pino</surname><given-names>SM</given-names></name><name><surname>Cognetti</surname><given-names>F</given-names></name><name><surname>Fabi</surname><given-names>A</given-names></name></person-group><article-title>COX-2 targeting in cancer: a new beginning?</article-title><source>Ann Oncol</source><year>2008</year><volume>19</volume><fpage>1209</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">18477580</pub-id></element-citation></ref><ref id="B022"><label>22</label><element-citation publication-type="journal"><person-group><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Sica</surname><given-names>A</given-names></name><name><surname>Balkwill</surname><given-names>F</given-names></name></person-group><article-title>Cancer-related inflammation.</article-title><source>Nature</source><year>2008</year><volume>454</volume><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">18650914</pub-id></element-citation></ref><ref id="B023"><label>23</label><element-citation publication-type="journal"><person-group><name><surname>Cha</surname><given-names>YI</given-names></name><name><surname>DuBois</surname><given-names>RN</given-names></name></person-group><article-title>NSAIDs and cancer prevention: targets downstream of COX-2.</article-title><source>Annu Rev Med</source><year>2007</year><volume>58</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">17100552</pub-id></element-citation></ref><ref id="B024"><label>24</label><element-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>AJ</given-names></name><name><surname>Kang</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Ha</surname><given-names>SD</given-names></name><name><surname>Cha</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name></person-group><article-title>The chemopreventive potential and anti-inflammatory activities of Korean black ginseng in colon26-M3.1 carcinoma cells and macrophages.</article-title><source>J Korean Soc Appl Biol Chem</source><year>2010</year><volume>53</volume><fpage>101</fpage><lpage>105</lpage></element-citation></ref><ref id="B025"><label>25</label><element-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>BK</given-names></name><name><surname>Yoon</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>HO</given-names></name><name><surname>Park</surname><given-names>YM</given-names></name></person-group><article-title>Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice.</article-title><source>Int Immunopharmacol</source><year>2011</year><volume>11</volume><fpage>280</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">21118672</pub-id></element-citation></ref><ref id="B026"><label>26</label><element-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>SN,</given-names></name><name><surname>Ha</surname><given-names>YW</given-names></name><name><surname>Shin</surname><given-names>H</given-names></name><name><surname>Son</surname><given-names>SH</given-names></name><name><surname>Wu</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name></person-group><article-title>Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLCELSD and its application to quality control.</article-title><source>J Pharm Biomed Anal</source><year>2007</year><volume>45</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">17560064</pub-id></element-citation></ref><ref id="B027"><label>27</label><element-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Shim</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>YB</given-names></name><name><surname>Kwon</surname><given-names>J</given-names></name></person-group><article-title>Modulation of LPS-Stimulated Astroglial Activation by Ginseng Total Saponins.</article-title><source>J Ginseng Res</source><year>2011</year><volume>35</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.5142/jgr.2011.35.1.080</pub-id></element-citation></ref></ref-list></back></article>